Tenn. Comp. R. & Regs. 1145-01-.02 - REPORTING TO THE DATABASE
(1) Dispensing
healthcare practitioners or their agents shall submit the data that is required
by T.C.A. §
53-10-305 in one of the following forms:
(a) An electronic device compatible with the
Committee's receiving device or the receiving device of the Committee's agent;
or
(b) Other electronic or data
format approved by the Committee.
(c) Veterinarians shall not be required to
use a computerized system in order to submit required information to the
Database. Instead, veterinarians may elect to submit information to the
Database by any appropriate method set forth in the Tennessee Controlled
Substance Database Data Collection Manual.
(2) The information to be included in the
Database shall be submitted each business day and no later than the close of
business on the business day after dispensing for all controlled substances as
set forth in the Prescription Safety Act of 2016. Consistent with the
Prescription Safety Act of 2016, veterinarians shall only be required to submit
information to the Database every fourteen days.
(3) The dispensing healthcare practitioner or
its agent, excluding a veterinarian, shall transmit or enter into the data
collection application the data that is required pursuant to T.C.A. §
53-10305 in the 2009 version of the Telecommunications Format for Controlled
Substances established by the American Society for Automation in Pharmacy
(ASAP). Beginning on July 1, 2022, the dispensing healthcare practitioner or
its agent, excluding a veterinarian, shall transmit or enter into the data
collection application the data that is required pursuant to T.C.A. §
53-10-305 in the June 2017 version 4.2A of the Telecommunications Format for
Controlled Substances established by the ASAP. The committee shall have the
power to grant a waiver of the requirement to report or submit data in the June
2017 version 4.2A of the Telecommunications Format for Controlled Substances
established by the ASAP upon a showing of hardship. Such waiver shall be good
for up to two (2) years. The dispenser shall report, at minimum, all required
fields even when reporting using alternative method as per waiver.
(4) Each controlled substance prescription
required to be reported to the database shall be serially numbered by the
unique dispenser.
(5) Each
dispenser or dispenser's agent shall, regarding each controlled substance in
Schedules II-V dispensed, submit to the database all of the following
information in accordance with the guidance in the CSMD Data Collection Manual:
(a) Dispenser Information:
1. Dispenser NPI Number, if
available;
2. Either an NCPDP or
NABP Provider ID, if available, as set forth in the CSMD Data Collection
Manual;
3. DEA Number;
4. Dispenser's Name including the name of the
Dispensing Organization or Individual where applicable;
5. Dispenser's Address (Street, City, State,
Zip);
6. Dispenser's Phone
Number;
7. Dispenser's Contact
Person's Name;
8. Dispenser's Chain
Site ID, if available; and
9. For
Pharmacy Dispensers, the Pharmacy's Tennessee License Number; and
(b) Patient Information:
1. ID qualifier of Patient Identifier
(assigning authority);
2. ID
qualifier (identifies what type), as set forth in the CSMD Data Collection
Manual ID of Patient;
3. Patient's
Name, including First, Last, and Middle names as well as Name Prefixes and
Suffixes. Prefixes and Suffixes shall not be included in the First, Last, or
Middle name fields. For non-human patients the last name of the patient shall
be the owner's family name. The first name shall be the name of the
animal;
4. Patient Address
including street address, city, state, and zip code. For non-US residents or
others without an address information may be collected pursuant to the
instructions in the CSMD Data Collection Manual;
5. Patient Phone Number;
6. Patient's Date of Birth;
7. Patient's Gender;
8. Patient's Species; and
9. Patient Location Code, if available;
and
(c) Dispensing
Information:
1. Reporting Status in compliance
with the CSMD Data Collection Manual;
2. Prescription Number;
3. Prescription Written Date;
4. Prescription Refills
5. Prescription Fill Date;
6. Prescription Refill Number, if
applicable;
7. Product ID
Qualifier, as set forth in the CSMD Data Collection Manual; and
8. Product ID;
9. Quantity Dispensed;
10. Days' Supply (calculated or estimated
number of days the medication will cover);
11. Drug Dosage Units Code;
12. Transmission Form of Prescription Origin
Code;
13. Partial Fill
Indicator;
14. Dispenser NPI
Number, if available;
15.
Classification Code for Payment Type;
16. Prescription Sold Date;
17. Electronic Prescription Reference and
Electronic Order Number, if available;
18. Quantity Prescribed (on the original
prescription); and
19. Whether a
prescription contains a notation that it was written pursuant to a medical
necessity Diagnosis Code (ICD-10), if available.
(d) Prescriber Information:
1. Prescriber's National Providers Identifier
(NPI) Number, if available;
2.
Prescriber DEA number;
3.
Prescriber DEA suffix, if applicable;
4. Prescriber last name, first name, middle
name;
5. Prescriber Phone Number;
and
6. Prescriber XDEA Number, if
applicable.
(e) Compound
Drug Information. If a compound substance is dispensed, the Compound Segment of
ASAP shall be used to report:
1. Ingredient
Sequence Number;
2. Product ID
Qualifier, as set forth in the Data Collection Manual;
3. Product ID;
4. Compound ingredient quantity;
and
5. Compound drug dosage units
code.
(6) All
the data fields in Rule 1145-01-.02(5) are taken directly from the June 2017
version 4.2A of the Telecommunications Format for Controlled Substances
established by the ASAP. It is expected that new versions of the
Telecommunications Format for Controlled Substances established by ASAP will
remain consistent with these data fields. Guidance on the use of the fields
consistent is provided in the CSMD Data Collection Manual. In cases where
certain fields are not available processes for reporting are contained in the
CSMD Data Collection Manual.
(7) If
the dispenser does not have an automated recordkeeping system capable of
producing an electronic report of the required data in the format established
by the ASAP, or for whom electronic reporting would cause an undue hardship as
determined by the Committee, then that dispenser may request a waiver from the
electronic reporting requirement from the Committee or its designee. The waiver
may be valid for up to two (2) years from ratification by the Committee or its
designee.
(8) If the Committee or
its designee grants the healthcare practitioner a waiver from the electronic
reporting requirement, then the dispenser shall comply with an alternative
method of reporting the data as determined by the Committee or its designee,
such as submitting the required data in writing on a form approved by the
Committee.
(9) In reporting the
appropriate payment type, the healthcare practitioner shall, where possible,
report discount cards as code 99 in the Classification Code for Payment
Type.
Notes
Authority: T.C.A. §§ 53-10-303(f), 53-10-305(e), and 53-10-311(b).
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.